Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
SEL-8, a nuclear protein required for LIN-12 and GLP-1 signaling in caenorhabditis elegans
Numerous lawsuits have been filed against Teva Pharmaceuticals, the manufacturer of Paragard, alleging that the company failed to warn about the potential risks
Wegovy (semaglutide): Patients on the 2.4 mg dose lost an average of 15% of their body weight over 68 weeks
Both TZP and Sema demonstrated effective glycemic control in diabetic rats when delivered via PNP hydrogel formulations, with notable differences in consistency and magnitude of therapeutic response
Zepbound has been approved for two distinct conditions: Chronic weight management in adults with obesity or overweight plus a weight-related medical problem (FDA approval, November 2023) Moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity (FDA approval, December 2024), the first medication ever approved for OSA This dual-indication approval is unique
Dietary intervention in patients with gestational diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials on maternal and newborn outcomes
